Per Lindström Selected Research

Ischemic Stroke

9/2012

Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Per Lindström Research Topics

Disease

3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2007 - 02/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 09/2007 - 02/2003
2	Insulin Resistance 10/2016 - 07/2002
2	Obesity 10/2016 - 05/2007
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2007 - 02/2003
1	Ventral Hernia 01/2021
1	Pain (Aches) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2016
1	Ischemic Stroke 09/2012
1	Infarction (Infarctions) 09/2012
1	Stroke (Strokes) 09/2012
1	Cognitive Dysfunction 09/2007
1	Neoplasms (Cancer) 05/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2006
1	Hyperinsulinism (Hyperinsulinemia) 08/2006
1	Hyperglycemia 11/2004
1	Diabetes Complications 07/2002

Drug/Important Bio-Agent (IBA)

2	LeptinIBA 10/2016 - 05/2007
2	Insulin (Novolin)FDA Link 05/2007 - 11/2004
2	C-PeptideIBA 01/2007 - 02/2003
1	vinpocetineIBA 09/2012
1	Biomarkers (Surrogate Marker)IBA 09/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2007
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 08/2006
1	Protons (Proton)IBA 11/2004
1	Amiloride (Midamor)FDA LinkGeneric 11/2004
1	arylesteraseIBA 02/2003
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2003
1	Adenosine Triphosphatases (ATPase)IBA 02/2003

Therapy/Procedure

2	Therapeutics 01/2007 - 02/2003
1	Length of Stay 01/2021
1	Glycemic Control 07/2002